Sigma Planning Corp Cognition Therapeutics Inc Transaction History
Sigma Planning Corp
- $3.07 Billion
- Q4 2024
A detailed history of Sigma Planning Corp transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Sigma Planning Corp holds 614,490 shares of CGTX stock, worth $258,085. This represents 0.01% of its overall portfolio holdings.
Number of Shares
614,490
Previous 197,190
211.62%
Holding current value
$258,085
Previous $92,000
400.0%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CGTX
# of Institutions
50Shares Held
13.4MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$2.52 Million4.39% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$926,2580.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.24MShares$520,6180.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$210,0000.0% of portfolio
-
Voss Capital, LLC Houston, TX500KShares$210,0000.03% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $9.54M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...